BioCentury
ARTICLE | Clinical News

Vatiquinone regulatory update

June 16, 2014 7:00 AM UTC

Edison said FDA granted EPI-743 Orphan Drug designation to treat Leigh syndrome. The compound is in a U.S. Phase IIb trial and a Japanese Phase IIb/III trial for the indication, for which it already h...